Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Number of holders
-
272
-
Total 13F shares, excl. options
-
55,943,514
-
Shares change
-
+2,500,233
-
Total reported value, excl. options
-
$3,597,678,709
-
Value change
-
+$179,201,893
-
Put/Call ratio
-
102%
-
Number of buys
-
126
-
Number of sells
-
158
-
Price
-
$64.35
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2020
As of 31 Mar 2020 TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) had 272 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,943,514 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Invesco Ltd., FEDERATED HERMES, INC., STATE STREET CORP, GILDER GAGNON HOWE & CO LLC, BROWN CAPITAL MANAGEMENT LLC, and EAGLE ASSET MANAGEMENT INC.
This table shows 272 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.